20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.29.2018
The World Health Organization (WHO) presents its compliments to Member States and
Associate Members and invites them to nominate experts on in vitro diagnostics to be a
candidate for membership to the Strategic Advisory Group of Experts on In Vitro
Diagnostics (SAGE IVD).
Since 2017, WHO constitutes and maintains a roster of experts to select each year’s SAGE
IVD, an advisory body to WHO on matters of global policies and strategies related to IVDs. Its
role includes to provide technical advice on global policies and strategies, ranging from
development, assessment, use of IVDs and their linkages with other health interventions; suggest
guiding principles for how, when and where to use particular IVDs in national, regional and
global settings; review the pipeline of existing and innovative IVDs for noncommunicable
diseases, rare diseases and infectious diseases, including for emerging pathogens and existing
public health conditions of international concern, and identify major gaps; and provide advice to
WHO Secretariat for the development of the WHO List of Essential Diagnostics (EDL).
It is requested that the candidate has expertise in one or more of the following settings:
• Ministry of health, (policy-making on IVD or medical devices);
• national reference laboratory or laboratories in national teaching public hospitals;
• assessment, validation, clinical trials, regulatory body;
• selection, procurement and supply of IVDs;
• pricing/reimbursement for IVDs.
To be considered, candidates must be proficient in English and be able to demonstrate that
they have the expertise, skills and experience to meet the criteria described below:
• an understanding of the IVD issues covered by the Strategic Advisory Group
(SAGE IVD);
• an outstanding record of achievement and personal credibility within own field,
appropriate to the remit of SAGE IVD;
• experience in international settings; resource-limited settings; operating at a strategic
level in the public or other sectors and/or working effectively in high level advisory
groups or committees.
Nominated candidates should submit their CV, motivation letter and a signed Declaration
of Interest to:
[email protected].
Page 2
C.L.29.2018
More detailed information on SAGE IVD and formats are available at the following link:
http://www.who.int/medicines/news/2017/strategic_advisory_group_experts_in_vitro_iagnostics
/en/.
On related information:
The first edition of the WHO Model List of Essential Diagnostics (EDL) was published on
the WHO website in May 2018
(http://www.who.int/medical_devices/diagnostics/WHO_EDL_2018.pdf).
It is foreseen that every year new tests and new information will be added, regarding
neglected tropical diseases, health emergencies and outbreaks, antimicrobial resistance and other
noncommunicable diseases. More information is available on:
http://www.who.int/medical_devices/diagnostics/WHO_Essential_Diagnostics_List_2019_appli
cation/
The next meeting of the SAGE IVD is planned to take place in WHO headquarters from
18 to 22 March 2019 and will include one open day for Member States’ participation.
More information on the EDL, SAGE IVD and updates of the list, are available at:
http://www.who.int/medical_devices/diagnostics/Selection_in-vitro_diagnostics/en/.
Questions can be addressed by email to
[email protected].
The World Health Organization takes this opportunity to renew to Member States and
Associate Members the assurance of its highest consideration.
GENEVA, 3 September 2018
Dear Member States of the World Health Organization,
Please find attached, in the six official languages, C.L.29.2018.
Best regards,
Department for Governing Bodies
World Health Organization